Benjamin Gille
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
Journal: Alzheimer's research & therapy
Published: September 10, 2020
Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: September 06, 2018
Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults.
Journal: Journal of neurochemistry
Published: August 10, 2018
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Journal: Neuropathology and applied neurobiology
Published: February 09, 2018
Automation on an Open-Access Platform of Alzheimer's Disease Biomarker Immunoassays.
Journal: SLAS technology
Published: January 19, 2018
Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: June 06, 2017
Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 11, 2016
Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.
Journal: Neurology
Published: September 24, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026